Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-27

Clinical Trial Update: Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing co-administration of amlodipine/atorvastatin versus amlodipine alone in patients with hypertension and dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • amlodipine/atorvastatin

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Hyperlipidemia | Phase 4 | Status: COMPLETED